17 Aug 2009
Self-management for men with lower urinary tract symptoms.
03 Aug 2009
Suks Minhas speaks about Erectile Dysfunction (Impotence)
14 Jul 2009
New NHS Position for Ken Anson
02 Jul 2009
First UK HIFU data published
30 Jun 2009
'I've seen big men reduced to tears'
25 Jun 2009
Help with Impotence
11 Jun 2009
The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures.
04 Jun 2009
Case study: the surgical management of angiokeratoma resulting from radiotherapy for penile cancer.
12 May 2009
Prostate Health Check
27 Apr 2009
New Position on NHS for Dan Wood
18 Apr 2009
Minimally-invasive technologies in uro-oncology
The role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Click here for summary.
07 Apr 2009
Dan Wood is running the London marathon
02 Apr 2009
New Urology Nurse for LUA
As we say a sad farewell to Roelinda Smith (Urology Clinical Nurse Specialist) we welcome Deidre Vlotman (Urology Nurse) to the London Urology Associates. Deidre completed her regsitered nurse training in South Africa before joining Spires private hospital in Manchester 8 years ago. On the surgical ward there she has gained invaluable experience caring for urological patients. She now brings this experience to LUA.
25 Mar 2009
Paraganglioma of the spermatic cord: case report and review of the literature
Suks Minhas was involved in the review of a case of paraganglioma of the spermatic cord which rarely occurs. Click here for summary.
19 Mar 2009
All men over 50 could be screened for prostate cancer
The Daily Telegraph reported on the European Randomised Study of screening for Prostate Cancer, which looked at 182 000 men aged between 50 - 74 and found that screening programmes could prevent 20% of deaths from prostate cancer which would be the equivalent of 2000 lives a year in Britian.
Mark Emberton commented: “It’s interesting that this finding is positive, that it shows that screening saves lives, as many thought it would not,” he said.
“It is good that the Government is planning to look at its implications for policy, especially if we can reduce the side effects of treatment in the future. GPs should be prepared for more men coming forward in the light of this study and asking for a PSA test.”
For a link to the full article click here.
12 Mar 2009
Photodynamic therapy for prostate cancer--a review of current status and future promise.
Mark Emberton has co-authored a review on the trial being run at University College Hospitals, London using Photodynamic therapy as a treatment for prostate cancer.
'Debate is ongoing about the treatment of organ-confined prostate cancer, particularly in men who have low-risk disease detected by PSA screening. A balance is needed between the harms and benefits of treatment.'
Click here for summary.
05 Mar 2009
Evaluation of the accuracy of 3-dimensional ultrasonography of the kidney using an in vitro renal model.
Ken Anson co-published a paper on a study evaluating the accuracy of 3-D ultrasounography.
'Three-dimensional ultrasonography (3DUS) has recently become a reality because of advances in ultrasound probes and machine processing ability. We have developed an anthropomorphic phantom of the human loin to assess both the accuracy of 3DUS of the kidney and its potential usefulness for training in ultrasonographically guided percutaneous renal intervention.'
Click here for summary.
25 Feb 2009
Hormone therapy: a revolution in understanding prostate cancer.
Mark Emberton published an article in the Lancet Oncology looking at the role of hormone therapy in understanding prostate cancer. Click here for the summary.
16 Feb 2009
A tertiary experience of vesico-vaginal and urethro-vaginal fistula repair: factors predicting success
Dan Wood contributed to a retrospective review carried out at the Univeristy College Hospitals London, to review the outcomes of all patients referred with vesico-vaginal and urethro-vaginal fistulae. The purpose was to investigate the patient, fistula and surgical factors relevant to success. Click here for the summary.
Mark Emberton is involved in a study of a new technique for diagnosising prostate cancer. Computer-aided ultrasonography (histoscanning) can identifytumour foci that are at least 0.5 ml. In this small study histoscanning was performed on men with known prostate cancer who were scheduled for surgery. The results of the scans were then compared to the actual histology results of the removed prostates. In this small study histoscanning accurately detected all tumour foci of at least 0.5 ml. To read the summary click here.